Close Menu

NEW YORK – NanoString Technologies on Sunday reported preliminary fourth quarter product and service revenue growth of 12 percent.

For the quarter ended Dec. 31, 2020, NanoString estimated product and service revenues of $35.7 million, including nCounter revenues of $23.5 million and $12.2 million in GeoMx digital spatial profiler revenues.

The nCounter instrument installed base grew to approximately 950 systems by the end of the quarter, while the GeoMx installed base grew to approximately 130 systems.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.